A Study to Evaluate if Blood and Spinal Fluid can be used for Future Tests to Diagnose, Treat and Give Prognosis to Patients with Inflammatory Central Nervous System (CNS) Diseases


About this study

This research is being done to see if blood and spinal fluid can be used for future diagnostic tests to help diagnose, treat and give prognosis to patients with inflammatory CNS diseases.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients undergoing evaluation at Mayo Clinic to investigate the possibility of an inflammatory central nervous system (CNS) disease.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Andrew McKeon, M.B., B.Ch., M.D.

Closed for enrollment

More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer